Clinical Trial Update: Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pleconaril nasal spray for reducing common cold symptoms and asthma exacerbations after rhinovirus exposure; results completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Common Cold

Drugs mentioned

• Pleconaril nasal spray (pleconaril)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma, Common Cold | Phase 2 | Status: COMPLETED | Results posted: 2013-10-31